Journal article
CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
Oncotarget, Vol.6(10), pp.8313-8322
04/10/2015
DOI: 10.18632/oncotarget.3228
PMID: 25829252
Abstract
CD133 has been implicated as a cancer stem cell (CSC) surface marker in several malignancies including pancreatic cancer. However, the functional role of this surface glycoprotein in the cancer stem cell remains elusive. In this study, we determined that CD133 overexpression induced "stemness" properties in MIA-PaCa2 cells along with increased tumorigenicity, tumor progression, and metastasis in vivo. Additionally, CD133 expression induced epithelial-mesenchymal transition (EMT) and increased in vitro invasion. EMT induction and increased invasiveness were mediated by NF-κB activation, as inhibition of NF-κB mitigated these effects. This study showed that CD133 expression contributes to pancreatic cancer "stemness," tumorigenicity, EMT induction, invasion, and metastasis.
Details
- Title: Subtitle
- CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
- Creators
- Alice Nomura - University of MinnesotaSulagna Banerjee - University of MinnesotaRohit Chugh - University of MinnesotaVikas Dudeja - University of MinnesotaMasato Yamamoto - University of MinnesotaSelwyn M Vickers - University of MinnesotaAshok K Saluja - University of Minnesota
- Resource Type
- Journal article
- Publication Details
- Oncotarget, Vol.6(10), pp.8313-8322
- DOI
- 10.18632/oncotarget.3228
- PMID
- 25829252
- NLM abbreviation
- Oncotarget
- ISSN
- 1949-2553
- eISSN
- 1949-2553
- Grant note
- T32 DA007097-32 / NIDA NIH HHS R01 CA184274 / NCI NIH HHS R01 CA170946 / NCI NIH HHS R01-CA184274 / NCI NIH HHS R01-CA170946 / NCI NIH HHS R01 CA124723 / NCI NIH HHS T32 DA007097 / NIDA NIH HHS
- Language
- English
- Date published
- 04/10/2015
- Academic Unit
- Anatomy and Cell Biology; Surgery
- Record Identifier
- 9985244572102771
Metrics
1 Record Views